Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 1/20 | 0.42 |
| ▸ | AMDHD2 | Q9Y303 | 1/20 | 0.40 |
| ▸ | F2 | P00734 | 1/20 | 0.37 |
| ▸ | SERPINC1 | P01008 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 4/20 | 0.36 |
| ▸ | FGF1 | P05230 | 1/20 | 0.33 |
| ▸ | FGF2 | P09038 | 1/20 | 0.33 |
| ▸ | HK2 | P52789 | 5/20 | 0.32 |
| ▸ | HK1 | P19367 | 4/20 | 0.32 |
| ▸ | FBP1 | P09467 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 3/20 | 0.30 |
| ▸ | CA1 | P00915 | 3/20 | 0.30 |
| ▸ | CA9 | Q16790 | 3/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13286928 | 1.00 | F10 (0.42) | F10AMDHD2F2SERPINC1CA2 | |
| SCHEMBL21067663 | 1.00 | F10 (0.42) | F10AMDHD2F2SERPINC1CA2 | |
| SCHEMBL7209918 | 1.00 | F10 (0.42) | F10AMDHD2F2SERPINC1CA2 | |
| SCHEMBL7209912 | 1.00 | F10 (0.42) | F10AMDHD2F2SERPINC1CA2 | |
| SCHEMBL1009127 | 1.00 | F10 (0.42) | F10AMDHD2F2SERPINC1CA2 | |
| SCHEMBL16728926 | 1.00 | F10 (0.42) | F10AMDHD2F2SERPINC1CA2 | |
| SCHEMBL15449484 | 0.87 | F10 (0.36) | F10AMDHD2F2SERPINC1CA2 | |
| SCHEMBL29535532 | 0.85 | F10 (0.48) | F10F2SERPINC1FGF1FGF2 | |
| SCHEMBL29534894 | 0.85 | F10 (0.43) | F10AMDHD2F2SERPINC1CA2 | |
| SCHEMBL17340086 | 0.82 | F10 (0.57) | F10SERPINC1CA2FGF1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109477829-B | Nuclear magnetic resonance analysis method for glycosaminoglycan, heparin and derivatives thereof | 罗维药物实验室股份有限公司 | 2022-06-21 | — | — | CN | disclosed |
| US-10809212-B2 | Method for the analysis of glycosaminoglycans, and their derivatives and salts by nuclear magnetic resonance | LABORATORIOS FARMACÉUTICOS ROVI, S.A. (ES) | 2020-10-20 | — | — | US | disclosed |
| US-20200271601-A1 | Method for the Analysis of Glycosaminoglycans, and Their Derivatives and Salts by Nuclear Magnetic Resonance | LABORATORIOS FARMACÉUTICOS ROVI, S.A. (ES) | 2020-08-27 | — | — | US | disclosed |
| US-10705037-B2 | Method for the analysis of glycosaminoglycans, and their derivatives and salts by nuclear magnetic resonance | LABORATORIOS FARMACEUTICOS ROVI, S.A. (ES) | 2020-07-07 | — | — | US | disclosed |
| US-20190154601-A1 | Method for the Analysis of Glycosaminoglycans, and Their Derivatives and Salts by Nuclear Magnetic Resonance | LABORATORIOS FARMACEUTICOS ROVI, S.A. (ES) | 2019-05-23 | — | — | US | disclosed |